Skip to content
Homepage
Clinic directory

Clinics in Des Plaines, Illinois

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Des Plaines, IL

Peptide Therapy clinics in Des Plaines

Des Plaines has a northwest Chicago suburb near O'Hare, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across downtown Des Plaines, the O'Hare corridor, and the Park Ridge border range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Advocate Lutheran General and Northwest Community network. The scene here skews toward clinics serving airline, corporate, and healthcare professionals near O'Hare. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Des Plaines clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

1 Clinics

Body In Balance Chiropractic & Medical

Des Plaines, IL

Body In Balance Chiropractic & Medical in Des Plaines offers regenerative orthobiologics alongside chiropractic care. The practice provides Platelet-Rich Plasma Therapy and Shockwave Therapy for musc…

  • Vitamin IV Therapy
  • PRP Therapy
  • Shockwave Therapy
  • Arthritis Treatment
  • Cryotherapy
15 30 50 results per page

Regulatory context

A note on Illinois's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, limiting 503A pharmacy sourcing. Section 503A covers traditional compounding pharmacies; Section 503B covers FDA-registered outsourcing facilities held to cGMP.

  • Illinois Pharmacy Practice Act (225 ILCS 85)
    Governs pharmacy licensure and compounding under the Illinois Department of Financial and Professional Regulation.
  • Illinois Medical Practice Act (225 ILCS 60)
    Regulates physician prescribing and delegation.
  • 68 Illinois Administrative Code Part 1330
    Sets compounding standards consistent with USP 795 and USP 797.

The Illinois Department of Financial and Professional Regulation (IDFPR) oversees pharmacy inspections and compounding compliance. Non-resident pharmacies must hold a current Illinois non-resident permit. The IDFPR has taken action against pharmacies for sterile compounding deficiencies.

Peptide Therapy in Des Plaines, answered.

Des Plaines clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$300 to $500 per month for sermorelin or sermorelin plus ipamorelin blends. $400 to $750 per month for BPC-157 plus TB-500 protocols when available. $400 to $700 per month for peptide plus hormone optimization bundles. Expect $300 to $700 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Illinois clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any Des Plaines clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Illinois is a reduced-practice state for nurse practitioners, meaning NPs operate under a collaborative agreement with a supervising physician. MDs and DOs can prescribe peptides directly, and NPs prescribe under that collaboration. All prescriptions must be filled through a state-licensed 503A compounding pharmacy. The Illinois Department of Financial and Professional Regulation licenses prescribers and the Illinois Board of Pharmacy regulates 503A compounders. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some Des Plaines offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Illinois medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Illinois. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable Des Plaines clinics in downtown Des Plaines will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology